Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

15.05
Delayed Data
As of 11:41am ET
 -0.05 / -0.33%
Today’s Change
14.85
Today|||52-Week Range
33.00
-19.95%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Blight Andrew R
Chief Scientific Officer
Sale2/09/201767,586$22.41$1.5M-38.74%
Blight Andrew R
Chief Scientific Officer
Buy2/09/201767,586$22.13$1.5M-38.74%
Lawrence David /acorda/
Sale2/09/201763,183$22.32$1.4M-38.74%
Lawrence David /acorda/
Buy2/09/201763,183$22.13$1.4M-38.74%
Wasman Jane
President-International & General Counsel
Sale2/09/201754,536$22.30$1.2M-38.74%
Wasman Jane
President-International & General Counsel
Buy2/09/201754,536$22.13$1.2M-38.74%
Cohen Ronald
President & Chief Executive Officer
Sale12/14/201639,764$20.75$825.1K-27.05%
Cohen Ronald
President & Chief Executive Officer
Buy12/14/201640,172$15.49$622.3K-27.05%
Blight Andrew R
Chief Scientific Officer
Buy8/09/20169,754$22.13$215.9K-37.06%
Blank Burkhard
Chief Medical Officer
Sale12/01/201610,000$20.74$207.4K-25.43%
Page of 5